A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers

Daniel M. Halperin, Alexandria T. Phan, Ana O. Hoff, Marie Aaron, James C. Yao, Paulo M. Hoff

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences